Wiley Online Library : Fundamental & Clinical Pharmacology
20 followers 2 articles/week
Effects of the nerve growth factor and its carrier protein on the inflammatory response from human monocytes

Abstract Background The nerve growth factor (NGF) has been previously shown to be involved in cellular proliferation, differentiation, survival, or wound healing. This factor displays a variety of biological effects that yet remain to be explored. Previous data on cell lines show a pro-inflammatory role of NGF on monocytes. Objectives The objective...

Sun May 5, 2024 03:52
Cross‐reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database

Abstract Background Hypersensitivity reactions (HSR) are reported for the macrolides, lincosamides, and streptogramins (MLS) antibiotic family. Data about cross-reactivity among and between MLS remain scarce or controversial. Objectives The aim of this study was to provide an overview of hypersensitivity cross-reactions among MLSs based on data...

Sun May 5, 2024 03:52
Alpha‐1 adrenergic antagonists and the risk of hospitalization or death in non‐hospitalized patients with COVID‐19: A population‐based study

Abstract Background Alpha-1 receptor antagonists may interfere with IL-6 signaling and could therefore be a potential treatment for COVID-19. However, the effectiveness of these drugs in mitigating the risk of clinical deterioration among non-hospitalized patients with COVID-19 is unknown. Objectives The aim of this study is to examine the association...

Fri Apr 5, 2024 10:40
Dosing‐time, feeding, and sex‐dependent variations of everolimus pharmacokinetics in mice

Abstract Background Everolimus is an oral mammalian target of rapamycin (mTOR) inhibitor used as an immunosuppressant and anticancer. Its pharmacokinetics is highly variable, it has a narrow therapeutic window and shows chronotoxicity with the best time at ZT13 and worst time at ZT1 (ZT; Zeitgeber time, time after light onset) in the preclinical setting....

Sun Mar 24, 2024 03:51
GW9508 ameliorates cognitive dysfunction via autophagy pathway in streptozotocin‐induced mouse model of Alzheimer's disease

Abstract Background G protein-coupled receptor 40 (GPR40) is a potential drug target for Alzheimer's disease (AD), and its agonist GW9508 ameliorates cognitive impairment by intravenous administration. Objectives The present study was conducted to investigate the efficacy of GW9508 administered peripherally on cognitive dysfunction in streptozotocin...

Fri Mar 15, 2024 13:47
Synergistic effects of epoxyazadiradione (EAD) and paclitaxel against triple‐negative breast cancer cells

Abstract Background Triple-negative breast cancer (TNBC) is the most aggressive and chemo-resistant form of breast cancer subtype, and chemotherapy is a vital treatment option for that. Paclitaxel is an effective chemo drug for TNBC. However, in clinical settings, paclitaxel has adverse side effects. The synergistic combination is the most promising...

Thu Mar 14, 2024 19:52

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account